Tecsys Inc. (TSE:TCS – Free Report) – Equities research analysts at National Bank Financial decreased their FY2026 earnings per share (EPS) estimates for Tecsys in a note issued to investors on Sunday, December 8th. National Bank Financial analyst J. Shao now anticipates that the company will post earnings per share of $0.86 for the year, down from their previous forecast of $0.99. The consensus estimate for Tecsys’ current full-year earnings is $0.46 per share.
A number of other equities research analysts have also recently commented on TCS. Ventum Financial raised their price target on shares of Tecsys from C$45.00 to C$52.00 in a report on Friday, December 6th. Cormark lowered Tecsys from a “moderate buy” rating to a “hold” rating in a report on Monday, September 9th.
Tecsys Price Performance
The stock’s 50 day moving average is C$42.21 and its 200 day moving average is C$39.89. The firm has a market cap of C$668.21 million, a P/E ratio of 443.30 and a beta of 0.65. The company has a current ratio of 1.38, a quick ratio of 1.40 and a debt-to-equity ratio of 2.87. Tecsys has a 52-week low of C$29.20 and a 52-week high of C$45.35.
Insider Activity
In other Tecsys news, Director David Brereton sold 1,500 shares of the firm’s stock in a transaction on Friday, December 6th. The stock was sold at an average price of C$43.96, for a total value of C$65,940.00. Insiders own 17.05% of the company’s stock.
Tecsys Company Profile
Tecsys Inc engages in the development, marketing, and sale of enterprise-wide supply chain management software and related services in Canada, the United States, Europe, and internationally. The company offers warehouse management, distribution and transportation management, supply management at point-of-use and order management and fulfillment, as well as financial management and analytics solutions.
Further Reading
- Five stocks we like better than Tecsys
- Buy P&G Now, Before It Sets A New All-Time High
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Overbought Stocks Explained: Should You Trade Them?
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- How to trade using analyst ratings
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Tecsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tecsys and related companies with MarketBeat.com's FREE daily email newsletter.